MedTrace Logo

Pulsed Electromagnetic Fields for Analgesia Post Mastectomy

NCT06331793 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2024-03-26

No results posted yet for this study

Summary

Study aim is to test AlgoCare, a device that uses the technology PEMF (Pulsed ElectroMagnetic Fields) for the treatment of postoperative pain in oncological breast surgery, in order to demonstrate that the use of Algocare in the postoperative period allows for a reduction in pain intensity in terms of Numerical Rating Scale (NRS) score and use of analgesic drugs.

Conditions

  • Female Breast Cancer
  • Post Operative Pain

Interventions

DEVICE

Active AlgoCare

Device that emits Pulsed Electromagnetic Fields

DEVICE

Non-active AlgoCare

Device that doesn't emit Pulsed Electromagnetic Fields

Sponsors & Collaborators

  • European Institute of Oncology

    lead OTHER

Principal Investigators

  • Daniele Sances, MD · European Institute of Oncology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-09
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06331793 on ClinicalTrials.gov